![The location of the primary colon cancer has no impact on outcomes in patients undergoing cytoreductive surgery for peritoneal metastasis - Surgery The location of the primary colon cancer has no impact on outcomes in patients undergoing cytoreductive surgery for peritoneal metastasis - Surgery](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/d1ca3a66-70bb-49cc-be03-10fda5cf2638/gr1_lrg.jpg)
The location of the primary colon cancer has no impact on outcomes in patients undergoing cytoreductive surgery for peritoneal metastasis - Surgery
![Actualités | SNFGE.org - Société savante médicale française d'hépato-gastroentérologie et d'oncologie digestive Actualités | SNFGE.org - Société savante médicale française d'hépato-gastroentérologie et d'oncologie digestive](https://www.snfge.org/sites/default/files/SNFGE/TutoGastros/tutogastro-snfge_sibo_2022.png)
Actualités | SNFGE.org - Société savante médicale française d'hépato-gastroentérologie et d'oncologie digestive
![Discovery of biomarker candidates associated with the risk of short-term and mid/long-term relapse after infliximab withdrawal in Crohn's patients: a proteomics-based study | Gut Discovery of biomarker candidates associated with the risk of short-term and mid/long-term relapse after infliximab withdrawal in Crohn's patients: a proteomics-based study | Gut](https://gut.bmj.com/sites/default/files/highwire/gutjnl/70/8.cover-source.jpg)
Discovery of biomarker candidates associated with the risk of short-term and mid/long-term relapse after infliximab withdrawal in Crohn's patients: a proteomics-based study | Gut
![Chloé MELCHIOR | Assistant professor of Gastroenterology | MD PhD | Centre Hospitalier Universitaire Rouen, Rouen Chloé MELCHIOR | Assistant professor of Gastroenterology | MD PhD | Centre Hospitalier Universitaire Rouen, Rouen](https://i1.rgstatic.net/ii/profile.image/994657689432065-1614156281043_Q512/Chloe-Melchior-2.jpg)